America’s largest health insurers are urging doctors to stick with current standard treatments for diabetes instead of flocking to a new drug from Eli Lilly & Co that is showing it can provide life-saving results for one-third of patients.
EXCLUSIVE-US Insurers Hold Back Lilly’s Death-Defying Diabetes Drug
Reply